Innocan Pharma (INNPF) announced that it anticipates to list on NYSE American on or around January 7, 2026. Innocan is also conducting a concurrent offering of its securities.
Innocan expects that its common shares will continue to trade on the OTC Markets' OTCQB until the close of the market on or about January 6, 2026. Upon effectiveness of the listing on the NYSE American, trading on the OTCQB will terminate. Innocan's shares will continue to trade on the Canadian Securities Exchange under the symbol, INNO.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.